Timing of postoperative chemotherapy and prognosis in neoadjuvant-treated gastric cancer patients: a multicenter real-world cohort study
A postoperative chemotherapy timing of 6-8 weeks was associated with better survival and delayed recurrence in NLAGC patients. These findings suggest that the 6-8 week time-window should be a key timeframe for personalized postoperative adjuvant chemotherapy decisions.
Authors
- Ling-Kang Zhang (ORCID: https://orcid.org/0009-0004-0035-5634)
- Jian‐Xian Lin (ORCID: https://orcid.org/0000-0002-5006-4454)
- Chen-Bin Lv
- Hong-Hong Zheng
- Jian-Wei Xie (ORCID: https://orcid.org/0000-0001-9000-5638)
- Chao‐Hui Zheng (ORCID: https://orcid.org/0000-0001-8680-3127)
- Chang‐Ming Huang
- Hua‐Long Zheng (ORCID: https://orcid.org/0000-0002-2749-0113)
- Guang‐Tan Lin
- Qi-Yue Chen
- Bin-Bin Xu
Institutions
- Fujian Medical University (CN)
- Zhangzhou Municipal Hospital of Fujian Province (CN)
- Fujian Provincial Hospital (CN)
- Fuzhou University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-05-07
- DOI
- https://doi.org/10.1080/07853890.2025.2500690
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fujian Provincial Health Technology Project